Free Virtual Consultations. Corona Virus Related Cases Click Here.

Bicyclist Killed in Crash on Avenue 192 Near Road 200

Toyota Hits Bicycle in Fatal Strathmore Accident

Strathmore, CA (April 6, 2020) – An elderly man was killed in a bicycle crash in Strathmore. The fatal accident occurred on the morning of April 6 on Avenue 192.

A 76-year-old man from Strathmore was riding a bicycle on Avenue 192, near Road 200, when he was hit by a Toyota traveling east. The man was ejected from the bike. He was killed in the crash. The driver of the Toyota remained at the accident scene.

Our heartfelt condolences go out to the friends and loved ones of the victim.



November 19, 2019

1 Killed, 1 Injured in Crash on Interstate 80 Near Gilman Street

Car Crashes Into Disabled Vehicle in Fatal Berkeley Accident...

December 16, 2019

Kevin Hart Killed in Crash on Interstate 5 Near Charter Way

Child Killed When Police Car Rear-Ends Sedan in Fatal Stockton Accident...

December 31, 2019

Crash at Road 100 and Oakdale Avenue Causes Minor Injuries

2 Vehicles Involved in Tulare Accident...

Free Police Report Request

We offer free consultation. No office visit required, we will get back to you within 24 hours.

  • This field is for validation purposes and should be left unchanged.

What can we do for you?

  • Answer your legal question.
  • Provide a Free Case Evaluation.
  • Schedule an appointment.

Why Choose Us?

  • Available 24/7
  • Trusted Since 1990
  • Local to You
  • Recovered $350,000,000
  • 5 Star Reviews
  • Free Case Evaluation
  • VIP Service
  • No Win, No Fee

Latest Law Post

May 22, 2020

Johnson & Johnson Discontinues Talc-Based Baby Powder

baby powder new Johnson & Johnson discontinued its talc-based baby powders in the United States and Canada because thousands of lawsuits claiming it was contaminated with asbestos created a sales decline.

May 18, 2020

FDA Issues Warnings To Two Manufacturers Of Breast Implants

The U.S. Food and Drug Administration (FDA) just issued warning letters to two manufacturers of breast implants for failing to comply with regulatory requirements. The FDA sent a warning letter to Allergan for failure to comply with requirements to conduct post-approval studies assessing the risks and long-term safety of two separate breast implant models. Both breast implant models were voluntarily recalled last year. The FDA also sent a warning letter to Ideal Implant Incorporated. That letter was sent for failing to comply with adverse event reporting requirements and current good manufacturing practice requirements. The letter was prompted by an inspection which was conducted earlier in 2020.